Launch week offerEnds in00h00m00s

annual Promonthly Pro

Petra Huehnchen

Has grant

Attending

Charité - Universitätsmedizin Berlin

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Recent Grants

Grant: Open

NeuroCure female postdoc fellowship

Open Date: 2026-01-01

Close Date: 2027-12-01

Grant: Close

NeuroCure-SPARK: Predictors of chemotherapy-induced polyneuropathy identified with mass spectrometry (PERCIPIENCE)

Open Date: 2023-01-01

Close Date: 2024-12-01

Grant: Close

Prevention of paclitaxel-related neurological side effects with lithium - a randomized, double-blind, placebo-controlled, explorative phase-2 clinical trial to counteract chemotherapy-induced neurotoxicity (PREPARE)

Open Date: 2021-04-01

Close Date: 2025-12-01

Grant: Close

NeuroCure-SPARK: Biomarkers of neurological side effects of immune checkpoint inhibitor therapy (BENEFIT)

Open Date: 2021-01-01

Close Date: 2022-12-01

Grant: Close

Sprechstunde für Langzeitüberlebende mit gynäkologischen Tumorerkrankungen - Survivorship Clinic

Open Date: 2020-10-01

Close Date: 2024-09-01

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (18)

Wolfgang Boehmerle

Charite Universitatsmedizin Berlin Klinik für Neurologie mit Experimenteller Neurologie

GERMANY

View details

Richard Kovacs

Charité - Universitätsmedizin Berlin

GERMANY

View details

Werner Stenzel

Head of Neuromuscular Diagnostic and Research unit/ Professor Dr. med

Charité - Universitätsmedizin Berlin

GERMANY

View details

Matthias Endres

Prof. Dr. med

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

GERMANY

View details

Raphael Bernard-Valnet

SWITZERLAND

View details

Jennifer Kirwan

Professor of Metabolomics

Max Delbrück Center for Molecular Medicine

GERMANY

View details

Olaf Penack

GERMANY

View details

Sebastien Lhomme

Full Professor-Hospital Practitionner

Centre Hospitalier Universitaire de Toulouse

FRANCE

View details

Frederik Damm

Charité - Universitätsmedizin Berlin

GERMANY

View details

Ulrike Bruning

staff scientist

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Samuel Knauss

Charité - Universitätsmedizin Berlin

GERMANY

View details

Raphael Mohr

Charité - Universitätsmedizin Berlin

GERMANY

View details

Frank Konietschke

Charité - Universitätsmedizin Berlin

GERMANY

View details

Omar Hasan Ali

PI Glycodermatology

University of Zurich

SWITZERLAND

View details

Valeria Fernandez Vallone

Charité - Universitätsmedizin Berlin

GERMANY

View details

Markus Leo

Lab head / scientific stuff

University Hospital Essen

GERMANY

View details

Patrick Maschmeyer

Professor of AI-based Predictive Immune Analytics

University of Lübeck

GERMANY

View details

Lars Bullinger

Charité University Medicine

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Petra Huehnchen

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (13)

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy

Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Generation of ten human induced pluripotent stem cell lines (hiPSCs) from patients with and without Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Post Chemotherapy Cognitive Impairment (PCCI)

Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors.

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study.

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.

Collaborators (18)

Wolfgang Boehmerle

Richard Kovacs

Werner Stenzel

Matthias Endres

Raphael Bernard-Valnet

Jennifer Kirwan

Olaf Penack

Sebastien Lhomme

Frederik Damm

Ulrike Bruning

Samuel Knauss

Raphael Mohr

Frank Konietschke

Omar Hasan Ali

Valeria Fernandez Vallone

Markus Leo

Patrick Maschmeyer

Lars Bullinger

Make your next move.

Petra Huehnchen

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (13)

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy

Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)

HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Generation of ten human induced pluripotent stem cell lines (hiPSCs) from patients with and without Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Post Chemotherapy Cognitive Impairment (PCCI)

Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors.

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study.

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.

Collaborators (18)

Wolfgang Boehmerle

Richard Kovacs

Werner Stenzel

Matthias Endres

Raphael Bernard-Valnet

Jennifer Kirwan

Olaf Penack

Sebastien Lhomme

Frederik Damm

Ulrike Bruning

Samuel Knauss

Raphael Mohr

Frank Konietschke

Omar Hasan Ali

Valeria Fernandez Vallone

Markus Leo

Patrick Maschmeyer

Lars Bullinger

Make your next move.

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis